These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32208986)

  • 21. Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons.
    Halawa AH; Elgammal WE; Hassan SM; Hassan AH; Nassar HS; Ebrahim HY; Mehany ABM; El-Agrody AM
    Bioorg Chem; 2020 May; 98():103725. PubMed ID: 32199303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
    Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
    Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of new steroidal imidazo [1,2-a] pyridines: DNA binding studies, cleavage activity and in vitro cytotoxicity.
    Dar AM; Shamsuzzaman ; Gatoo MA
    Steroids; 2015 Dec; 104():163-75. PubMed ID: 26433147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and cytotoxic activities of a new benzo[c]phenanthridine alkaloid, 7-hydroxynitidine, and some 9-oxygenated benzo[c]phenanthridine derivatives.
    Nakanishi T; Suzuki M
    Org Lett; 1999 Oct; 1(7):985-8. PubMed ID: 10825951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of some 2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-arylethanones: antibacterial, DNA photocleavage, and anticancer activities.
    Kumar V; Kaur K; Karelia DN; Beniwal V; Gupta GK; Sharma AK; Gupta AK
    Eur J Med Chem; 2014 Jun; 81():267-76. PubMed ID: 24849271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
    Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
    Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of derivatives of NK109, 7-OH benzo[c]phenanthridine alkaloid, and evaluation of their cytotoxicities and reduction-resistant properties.
    Nakanishi T; Masuda A; Suwa M; Akiyama Y; Hoshino-Abe N; Suzuki M
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2321-3. PubMed ID: 11055347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DPP-IV Inhibitory Phenanthridines: Ligand, Structure-Based Design and Synthesis.
    Khalaf RA; Masalha D; Sabbah D
    Curr Comput Aided Drug Des; 2020; 16(3):295-307. PubMed ID: 30526469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-Step Synthetic Access to Isosteric and Potent Anticancer Nitrogen Heterocycles with the Benzo[c]phenanthridine Scaffold.
    Steinhauer TN; Girreser U; Meier C; Cushman M; Clement B
    Chemistry; 2016 Jun; 22(24):8301-8. PubMed ID: 27151929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substituted benzo[i]phenanthridines as mammalian topoisomerase-targeting agents.
    Makhey D; Li D; Zhao B; Sim SP; Li TK; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2003 Apr; 11(8):1809-20. PubMed ID: 12659767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of Dihydrazones as Potential Anticancer and DNA Binding Candidates: A Validation by Molecular Docking Studies.
    Sridhara MB; Rakesh KP; Manukumar HM; Shantharam CS; Vivek HK; Kumara HK; Mohammed YHE; Gowda DC
    Anticancer Agents Med Chem; 2020; 20(7):845-858. PubMed ID: 32096753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitor.
    Opoku-Temeng C; Dayal N; Hernandez DE; Naganna N; Sintim HO
    Chem Commun (Camb); 2018 May; 54(36):4521-4524. PubMed ID: 29629444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
    El-Sayed NA; Nour MS; Salem MA; Arafa RK
    Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, characterization, molecular modeling, and potential antimicrobial and anticancer activities of novel 2-aminoisoindoline-1,3-dione derivatives.
    Ahmed HE; Abdel-Salam HA; Shaker MA
    Bioorg Chem; 2016 Jun; 66():1-11. PubMed ID: 26986635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies.
    Kadagathur M; Devi GP; Grewal P; Sigalapalli DK; Makhal PN; Banerjee UC; Bathini NB; Tangellamudi ND
    Bioorg Chem; 2020 Jun; 99():103629. PubMed ID: 32272367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers.
    Abbass EM; Khalil AK; Mohamed MM; Eissa IH; El-Naggar AM
    Bioorg Chem; 2020 Nov; 104():104255. PubMed ID: 32927130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and Biological Evaluation of FTY720 (Fingolimod) Derivatives with Aromatic Head Group as Anticancer Agents.
    Lee T; Moon HS; Kim SW; Shrestha J; Shin SM; Lee JY; Kim S; Park EY; Baek DJ
    Chem Pharm Bull (Tokyo); 2018; 66(10):1015-1018. PubMed ID: 30270236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and anticancer activity of naphthoquinone derivatives.
    Shen XB; Wang Y; Han XZ; Sheng LQ; Wu FF; Liu X
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):773-785. PubMed ID: 32200656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly stable phenanthridinium frameworks as a new class of tunable DNA binding agents with cytotoxic properties.
    Parenty AD; Smith LV; Guthrie KM; Long DL; Plumb J; Brown R; Cronin L
    J Med Chem; 2005 Jul; 48(14):4504-6. PubMed ID: 15999988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, Synthesis, and Preliminary Bioactivity Evaluation of 2,7-Substituted Carbazole Derivatives as Potent Autotaxin Inhibitors and Antitumor Agents†.
    Wang W; Zhao F; Zhao Y; Pan W; Cao P; Wu L; Wang Z; Zhao X; Zhao Y; Wang H
    Anticancer Agents Med Chem; 2019; 19(2):256-264. PubMed ID: 30173652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.